INARI MEDICAL INC. - COMMON STOCK

Inari Medical to Announce First Quarter 2023 Financial Results

13 Apr 2023 16:01:00 By Nasdaq GlobeNewswire

FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System

06 Mar 2023 08:00:00 By Nasdaq GlobeNewswire

Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results

27 Feb 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Announce Fourth Quarter and Full Year 2022 Financial Results

07 Feb 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

31 Jan 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis

12 Jan 2023 08:00:00 By Nasdaq GlobeNewswire

Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance

10 Jan 2023 08:00:01 By Nasdaq GlobeNewswire

Inari Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference

21 Dec 2022 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

03 Nov 2022 16:01:01 By Nasdaq GlobeNewswire

Inari Medical Reports Third Quarter 2022 Financial Results

02 Nov 2022 16:05:01 By Nasdaq GlobeNewswire

Inari Medical Announces In-hospital and 30-day Outcomes from the Fully Enrolled CLOUT Registry and Results from Propensity-Score Matched Comparison of CLOUT vs. ATTRACT

31 Oct 2022 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Announce Third Quarter 2022 Financial Results

06 Oct 2022 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Announces Results from the Fully Enrolled 800-patient US Cohort of the FlowTriever FLASH Registry

19 Sep 2022 08:00:00 By Nasdaq GlobeNewswire

Inari Medical to Host First Analyst & Investor Day

02 Sep 2022 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Announces Three New Data Sets to be Presented During Late-Breaking Clinical Trial Sessions at the 2022 TCT and VEINS Conferences

01 Sep 2022 16:05:00 By Nasdaq GlobeNewswire

Inari Medical Announces Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis

30 Aug 2022 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Present at Upcoming Investor Conferences

25 Aug 2022 16:36:00 By Nasdaq GlobeNewswire

Inari Medical Announces Leadership Succession Plan

03 Aug 2022 16:06:00 By Nasdaq GlobeNewswire

Inari Medical Reports Second Quarter 2022 Financial Results

03 Aug 2022 16:05:01 By Nasdaq GlobeNewswire

Inari Medical to Announce Second Quarter 2022 Financial Results

18 Jul 2022 16:01:00 By Nasdaq GlobeNewswire